Viewing StudyNCT00246662



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00246662
Status: COMPLETED
Last Update Posted: 2017-03-30
First Post: 2005-06-30

Brief Title: Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
Sponsor: Sunesis Pharmaceuticals
Organization: Sunesis Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Leukemia Lymphocytic Acute
Leukemia Nonlymphocytic Acute
Leukemia Myeloid Chronic
Keywords:
Name View
Myelodysplastic Syndromes View
Leukemia View
Hematologic View
Blood View
Cancer View
Malignancy View